Omega-3 fish oil reached the brain in a 2-year trial — but produced no cognitive benefit

Americans spend more than a billion dollars a year on fish oil supplements, largely on the strength of omega-3’s reputation for brain health. A rigorously designed 2026 USC/Keck Medicine trial tested that reputation directly — confirming the omega-3 actually reaches the brain, but finding it made no measurable difference to cognition or Alzheimer’s-related brain changes.

How the trial was designed

365 adults aged 55-80 who rarely ate fish (and were therefore likely to be lower in baseline omega-3) were randomly assigned to a daily high-dose DHA supplement (2,000 mg) or a placebo, in a two-year, double-blind, placebo-controlled design — the gold standard for this kind of question. Nearly half the participants (47%) carried the APOE4 gene, the strongest known genetic risk factor for late-onset Alzheimer’s, making this a population where a real benefit, if one existed, would be more likely to show up.

The supplement did what it was supposed to do — mechanically

Researchers measured DHA directly in cerebrospinal fluid and confirmed levels rose by an average of 17% after six months, proving the omega-3 successfully crossed into the central nervous system. This matters because it rules out the simplest explanation for a null result (that the supplement just isn’t absorbed or doesn’t reach its target).

"We all wish there was a silver bullet for preventing Alzheimer’s, but our findings showed that fish oil supplements do not appear to protect brain health." — Dr. Hussein Yassine, lead investigator, USC

But no benefit followed

Despite reaching the brain, DHA supplementation produced no improvement in memory or cognitive test performance relative to placebo, and brain MRI scans showed no slowing of hippocampal shrinkage — the region most associated with memory and Alzheimer’s progression. Two years is a substantial window for a cognitive intervention to show an effect if one were present.

A plausible explanation, and what still matters

The researchers suspect omega-3s may only be protective as part of an overall Mediterranean-style dietary pattern rather than as an isolated pill — the nutrient in isolation may not replicate the benefit of the whole dietary context it normally comes packaged in. Yassine’s own summary is blunt: "staying healthy throughout life remains the most powerful tool we have for reducing Alzheimer’s risk, including regular exercise, quality sleep and a balanced diet" — the fish oil pill is not a substitute for any of those.

This is a useful, evidence-based reason to deprioritize a fish oil capsule if brain health is your specific goal, and redirect that attention toward the training, sleep and whole-food nutrition targets Misi already tracks — the levers this trial suggests actually matter.